Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis.

Autor: Hasan, Kawa M.1,2 mah_kawa@yahoo.com, Elmeshhadany, Ahmed Y.1,2, Shabila, Nazar P.3
Zdroj: Sultan Qaboos University Medical Journal. Aug2022, Vol. 22 Issue 3, p393-399. 7p.
Databáze: Academic Search Ultimate